The value of F-18 FDG triple-head coincidence PET in the posttreatment evaluation of patients with lymphoma.
Huić
Drazen
D
Department of Nuclear Medicine and Radiation Protection, Division of Haematology, Zagreb University Hospital Centre, Zagreb, Croatia. dhuic@kbc-zagreb.hr
Mutvar
Andrea
A
Radman
Ivo
I
Grosev
Darko
D
Labar
Boris
B
Zuvić
Marijan
M
Dodig
Damir
D
Aurer
Igor
I
Nemet
Damir
D
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007089:Image Enhancement / Q000295:instrumentation / Q000379:methods; D008223:Lymphoma / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D049268:Positron-Emission Tomography / Q000295:instrumentation* / Q000379:methods*; D011379:Prognosis; D019275:Radiopharmaceuticals; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18